A new biopsy was performed under the IRB-approved observational study, “Molecular Mechanisms of Tumor Evolution and Resistance to Therapy” (MM-TERT)31, within the precision oncology SMMART-program at Oregon Health and Science University, Knight Cancer Institute. The gene discussed is TERT; the disease is neoplasm.